WHO ICTRP trial
Phase 1/2a study of pressurized intraperitoneal aerosol chemotherapy using…
KCT0010597 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0010597 |
|---|---|
| Public title | Phase 1/2a study of pressurized intraperitoneal aerosol chemotherapy using paclitaxel for mutli-drug resistant recurrent ovarian cancer |
| Scientific title | A Phase 1/2a Study to Evaluate the Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer With Peritoneal Metastasis (PIPAC-OvPac 1/2a) |
| Primary sponsor | Seoul National University Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase1/Phase2 |
| Countries | Korea, Republic of |
| Conditions | Neoplasms |
| Interventions | Drug, Medical Device : 1. Phase I Study 1) Primar objective : To determine the maximum tolerated dose and recommended phase II dose of pressurized intraperitoneal aerosol chemotherapy treatment with paclitaxel (20-140 mg/m²) in patients… |
| Registration date | Jun 9, 2025 |
| Target size | 53 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: